Tiziana (TLSA) CEO Ivor Elrifi Buys 321,423 Shares

What Happened Ivor Elrifi, CEO of Tiziana Life Sciences Ltd (TLSA), made two purchases of company stock on Aug 4 and Aug 5, 2026. He acquired 83,807 shares at $0.97 on Aug 4 (cost ~$81,293) and 237,616 shares at $1.00 on Aug 5 (cost $237,616), for a total of 321,423 shares and roughly $318,909. Both transactions are reported as purchases (transaction code P), indicating insider buys rather than sales.

Key Details

• Transaction dates and prices: Aug 4, 2026 — 83,807 shares @ $0.97; Aug 5, 2026 — 237,616 shares @ $1.00.
• Total shares acquired: 321,423; approximate total spent: $318,909.
• Filing: Form 4 filed with the SEC on Aug 6, 2026 (Accession No. 0001213900-26-085950) reporting period ended Aug 4–5, 2026.
• Shares owned after transaction: Not specified in the summary provided (see the full Form 4 for post-transaction holdings).
• No 10b5-1 plan, tax-withholding, gift, or other footnotes disclosed in the information provided.

Context These were direct purchases in the market (or private purchases reported as "P"), not option exercises or awards. Insider purchases are often watched by investors as a signal that executives are willing to buy equity, but they do not by themselves prove future performance. Check the full Form 4 for exact post-transaction ownership and any additional disclosures.